![Lisa Caperelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa Caperelli
Investor Relations Kontakt på
ARDELYX, INC.
Profil
Lisa M.
Caperelli is currently Director at National Investor Relations Institute and Head-Investor & Media Relations at Ardelyx, Inc. Former roles include Director-Investor Relations & Communications at PolyMedix, Inc. from 2009 to 2013, Executive Director-Investor & Strategic Relations at Immedica Pharma US, Inc. from 2014 to 2020, President & Director at NIRI Philadelphia Chapter from 2020 to 2022, Senior Director-Investor Relations at Advaxis, Inc. in 2014, Head-Investor Relations at Windtree Therapeutics, Inc. from 2001 to 2009, Head-Investor Relations at Harmony Biosciences Holdings, Inc. from 2020 to 2021, and Vice President-Investor Relations at Arbutus Biopharma Corp.
Education includes undergraduate studies at Delaware Valley University.
Aktiva positioner av Lisa Caperelli
| Företag | Position | Start |
|---|---|---|
| ARDELYX, INC. | Investor Relations Kontakt | 2026-03-01 |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Lisa Caperelli
| Företag | Position | Slut |
|---|---|---|
| HARMONY BIOSCIENCES HOLDINGS, INC. | Investor Relations Kontakt | 2021-01-01 |
| MARINUS PHARMACEUTICALS, INC. | Investor Relations Kontakt | 2020-03-01 |
| AYALA PHARMACEUTICALS, INC. | Investor Relations Kontakt | 2014-10-01 |
| POLYMEDIX, INC. | Investor Relations Kontakt | 2013-01-01 |
| WINDTREE THERAPEUTICS, INC. | Offentlig kommunikationskontakt | 2009-12-01 |
Lisa Caperellis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
59
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
PolyMedix, Inc.
 PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic small molecule compound drugs | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Delaware Valley University
 Delaware Valley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
NIRI Philadelphia Chapter
 NIRI Philadelphia Chapter Miscellaneous Commercial ServicesCommercial Services Provides timely information, cutting-edge programs and exciting networking opportunities to NIRI members | Commercial Services |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
